Buckle Up For Brand Take Off: FDA's Checklist For Pilot Participants
Executive Summary
FDA's proposed pilot to expedite proprietary name reviews would require sponsors to submit more comprehensive safety data, shifting the burden of testing look-a-like, sound-a-like names for medication errors. CDER and CBER recommend applicants submit the following information: